论文部分内容阅读
目的探讨CD7+急性髓系白血病(AML)治疗方法。方法报道3例CD7+AML及其治疗经过,并进行文献复习。结果3例用常规标准方案化疗2个疗程均未达到缓解,改用VDAM(VMAM)方案诱导治疗后获完全缓解。结论CD7+急性白血病可能是一独立的造血干细胞白血病,VDAM(VMAM)方案可作为CD7+急性髓系白血病诱导治疗方案,但需进一步研究。
Objective To investigate the treatment of CD7 + acute myeloid leukemia (AML). Methods 3 cases of CD7 + AML and its treatment were reported, and literature review. Results Three cases of conventional standard chemotherapy regimen did not reach remission in 2 courses, and the complete remission was achieved after induction with VDAM (VMAM) regimen. Conclusion CD7 + acute leukemia may be an independent hematopoietic stem cell leukemia. The VDAM (VMAM) regimen can be used as an induction therapy for CD7 + acute myeloid leukemia, but further study is needed.